ArticleOncotarget2015

Synergistic antitumor efficacy against the EGFRvIII+HER2+ breast cancers by combining trastuzumab with anti-EGFRvIII antibody CH12.

Wen Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.